258Tip A Phase II Trial of Loperamide (L) and Granulocyte Colony-Stimulating Factors (G-CSF) to Improve Sacituzumab Govitecan (SG) Tolerance in Patients (pts) with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer (mtnbc): PRIMED
ESMO Open(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined